Ophthalmological Devices
Aug 20, 2026
Empatica Secures FDA Clearance for Parkinson’s Monitoring; ZEISS CLINIC 360 Secures FDA 510(k) Clearance; BioLab Holdings Strengthens Tissue Restoration Portfolio With Addition of FastSkin® Technology; Surity™ Expands Urinary Incontinence Care Portfolio with New At-Home Urinary Management System; Galmed Announces Positive First-in-Human Proof-of-Concept Results for Colospan’s Intraoperative Tissue Assessment Platform; FastWave Medical Secures FDA IDE Approval for Pivotal Artero™ Peripheral IVL Trial
Empatica Received FDA Clearance for Parkinson's Monitoring On 19 August 2026, Empatica announced that its Health Monitoring Platform for Parkinson’s disease had received 510(k) clearance from the U.S. Food and Drug Administration. The clearance expanded Empatica’s clinical-grade monitoring capabilities int...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
